Leveraging All Intellectual Assets in Technology Commercialization Legal Strategy Development

Securing intellectual property is the heart of a commercialization strategy. This system includes the integration of downstream information, such as scientific data provided by contract research organizations (CROs) and contract manufacturing organizations (CMOs), into intellectual property strategies at the earliest stage. This enhances the potential for generating an increased revenue stream from licenses and higher valuation from investors. In addition, obtaining regulatory compliance can be advanced to an earlier stage by leveraging information from pre-clinical studies provided by the CROs and CMOs.

The diagram above illustrates the biocommercialization process which seeks to leverage collaborator feedback, business model information, and other data, all of which are considered at each step in an integrated process. Using this system enhances intellectual property strategy development by incorporating downstream legal and business considerations into protection intellectual property, e.g., a patent application. A patent application drafted to anticipate a potential licensee's product development and marketing strategies may enhance the value of the issued patent. Similarly, a patent application drafted to anticipate future governmental regulatory scrutiny may enhance the value of the issued patent,

back to top